Oppenheimer & Co’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.19M | Buy |
158,228
+13,685
| +9% | +$363K | 0.06% | 364 |
|
|
2025
Q1 | $3.49M | Buy |
144,543
+23,481
| +19% | +$567K | 0.05% | 385 |
|
|
2024
Q4 | $4.87M | Buy |
121,062
+18,738
| +18% | +$754K | 0.07% | 295 |
|
|
2024
Q3 | $6.48M | Buy |
102,324
+31,011
| +43% | +$1.96M | 0.1% | 225 |
|
|
2024
Q2 | $3.78M | Buy |
71,313
+22,369
| +46% | +$1.19M | 0.06% | 336 |
|
|
2024
Q1 | $4.01M | Buy |
48,944
+18,087
| +59% | +$1.48M | 0.07% | 322 |
|
|
2023
Q4 | $574K | Buy |
30,857
+14,038
| +83% | +$261K | 0.01% | 930 |
|
|
2023
Q3 | $186K | Buy |
16,819
+4,068
| +32% | +$45K | ﹤0.01% | 1272 |
|
|
2023
Q2 | $207K | Buy |
+12,751
| New | +$207K | ﹤0.01% | 1278 |
|